Keep up to date on the latest medical news at MDLinx - FREE!


  • Stay current on the latest medical literature, research and clinical news
  • MD jobs and physician job search at our new medical job Career Center
  • Receive invitations to paid market research
  • Search Clinical Trials and Medical Conferences

register to view free medical at articles at MDLinx

Follow Us

Posts by category

MDLinx Blog - Medical News and more.

Current Articles | RSS Feed RSS Feed

How much normal tissue should be excised around a liver metastasis from a colorectal cancer?

  
  
  
  
  

Interesting article addressing this question is now available as "Full Free Text" from Clin Cancer Res Published OnlineFirst April 29, 2011.

Original summary on MDLinx:

Holdhoff M et al. –Mutant tumor-specific DNA can be detected beyond the visible tumor margin, but never beyond 4 mm, even in patients whose tumors were larger prior to chemotherapy. These data provide a rational basis for determining the extent of surgical excision required in patients undergoing resection of liver metastases.

Methods

  • Evaluated 88 samples of tumor margins from 12 patients with metastatic colon cancer who each underwent partial hepatectomy of one to 6 liver metastases
  • Punch biopsies of surrounding liver tissue obtained at 4, 8, 12 and 16 mm from the tumor border
  • DNA from these biopsies analyzed by sensitive PCR-based technique, called BEAMing, for mutations of KRAS, PIK3CA, APC, or TP53 identified in corresponding tumor

Results

  • Mutations were identified in each patient's resected tumor and used to analyze the 88 samples circumscribing the tumor-normal border
  • Tumor-specific mutant DNA was detectable in surrounding liver tissue in five of these 88 samples, all within 4 mm of the tumor border
  • Biopsies 8, 12, and 16 mm from macroscopic visible margin were devoid of detectable mutant tumor DNA as well as of microscopically visible cancer cells
  • Tumors with significant radiologic response to chemotherapy were not associated with any increase in mutant tumor DNA in beyond 4 mm of main tumor
Read the full article here.
All Posts

Trending Medical Articles

Friday, Jul 11, 2014
Journal of Clinical Microbiology, 07/11/2014 Petty TJ, et al. – The study evaluate that high–throughput sequencing (HTS) provides the means to analyze clinical specimens at unprecedented molecular detail. However, results obtained in this pilot study indicate that the overall detection success rate, coupled to the ease of interpreting the analysis reports, makes it worth...Read More
Friday, Jul 18, 2014
PLOS ONE, 07/18/2014 Veit LE, et al. – The study aims to determine the vitamin D status of patients with inflammatory bowel disease (IBD) by comparing their serum 25(OH)D concentration to that of healthy controls. There is no difference in mean serum 25(OH)D concentration between children and adolescents with IBD and controls. However, IBD subjects with elevated ESR have significantly...Read More
Wednesday, Jun 11, 2014
Journal of Acupuncture and Tuina Science, 06/11/2014 Huang F, et al. – The purpose of this study is to observe the clinical efficacy of electroacupuncture plus interferential current therapy (ICT) in treating chronic fatigue syndrome (CFS), and to explore the mechanism. The result reveal that electroacupuncture plus ICT can produce a remarkable efficacy in treating CFS. Xiong Chen...Read More
Thursday, Jul 10, 2014
Journal of Leukocyte Biology, 07/10/2014 Shirey KA, et al. – The findings suggest that therapeutic manipulation of macrophage differentiation to enhance the alternatively activated macrophages (AAMs) phenotype is a viable approach for ameliorating RSV–induced disease. Stefanie N. Vogel and Kari Ann Shirey (07/21/2014) comments: RSV remains a leading cause of respiratory...Read More
Monday, Jul 21, 2014
Frontiers in Oncology, 07/21/2014 Saigal K, et al. – In this research, low–dose weekly carboplatin is added to Cx + RT for patients unsuitable for HD–DDP, to find out its efficacy. The researchers hypothesize that the addition of a well–tolerated cytotoxic chemotherapy agent may improve the therapeutic ratio of Cx + RT in patients who are poor candidates for more...Read More